Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 2,114,056 2.400% |
-2,226,284 (-51.29%) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Woodline Partners LP | 1,331,258 3.900% |
-245,309 (-15.56%) |
Filing History |
| 2025-02-14 4:05 pm Sale |
2024-12-31 | 13G | Guardian Pharmacy Services, Inc. GRDN |
Woodline Partners LP | 415,120 4.500% |
-153,011 (-26.93%) |
Filing History |
| 2024-11-14 1:01 pm Purchase |
2024-09-30 | 13G | Guardian Pharmacy Services, Inc. GRDN |
Woodline Partners LP | 568,131 6.200% |
568,131 (New Position) |
Filing History |
| 2024-11-14 1:01 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 4,340,340 5.700% |
4,340,340 (New Position) |
Filing History |
| 2024-11-14 1:00 pm Purchase |
2024-09-30 | 13G | Protara Therapeutics, Inc. TARA |
Woodline Partners LP | 1,576,567 7.400% |
1,576,567 (New Position) |
Filing History |
| 2024-11-14 1:00 pm Purchase |
2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA |
Woodline Partners LP | 4,048,653 7.700% |
4,048,653 (New Position) |
Filing History |
| 2024-02-12 4:38 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Woodline Partners LP | 1,140,632 2.200% |
1,140,632 (New Position) |
Filing History |
| 2024-02-12 4:33 pm Sale |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 12,500 0.400% |
-27,500 (-68.75%) |
Filing History |
| 2024-02-12 4:32 pm Sale |
2023-12-31 | 13G | OPY Acquisition Corp. I OHAA |
Woodline Partners LP | 0 0.000% |
-200,000 (Position Closed) |
Filing History |
| 2023-02-10 4:10 pm Sale |
2022-12-31 | 13G | Ascendant Digital Acquisition Corp. III ACDI |
Woodline Partners LP | 1,286,000 4.300% |
-626,500 (-32.76%) |
Filing History |
| 2023-02-10 4:10 pm Purchase |
2022-12-31 | 13G | OPY Acquisition Corp. I OHAA |
Woodline Partners LP | 200,000 8.100% |
200,000 (New Position) |
Filing History |
| 2023-02-10 4:09 pm Unchanged |
2022-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Woodline Partners LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-10 4:08 pm Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 40,000 9.700% |
-158,000 (-79.80%) |
Filing History |
| 2022-02-11 07:26 am Purchase |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
Woodline Partners LP | 2,000,000 8.400% |
2,000,000 (New Position) |
Filing History |
| 2022-02-11 07:25 am Purchase |
2021-12-31 | 13G | Ascendant Digital Acquisition Corp. III ACDI |
Woodline Partners LP | 1,912,500 6.400% |
1,912,500 (New Position) |
Filing History |
| 2022-02-11 07:23 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Woodline Partners LP | 198,000 8.600% |
198,000 (New Position) |
Filing History |
| 2022-02-11 07:22 am Unchanged |
2021-12-31 | 13G | MarketWise, Inc. MKTW |
Woodline Partners LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 07:20 am Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Woodline Partners LP | 685,273 4.800% |
685,273 (New Position) |
Filing History |
| 2021-02-16 4:35 pm Purchase |
2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS |
Woodline Partners LP | 814,756 5.400% |
814,756 (New Position) |
Filing History |